Cargando…

Metformin: From medieval age to new therapeutic targets

Detalles Bibliográficos
Autor principal: de Souza, Alexandre Leite
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771999/
https://www.ncbi.nlm.nih.gov/pubmed/19902037
http://dx.doi.org/10.4103/0973-3930.41984
_version_ 1782173790049927168
author de Souza, Alexandre Leite
author_facet de Souza, Alexandre Leite
author_sort de Souza, Alexandre Leite
collection PubMed
description
format Text
id pubmed-2771999
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-27719992009-11-09 Metformin: From medieval age to new therapeutic targets de Souza, Alexandre Leite Int J Diabetes Dev Ctries Letter to Editor Medknow Publications 2008 /pmc/articles/PMC2771999/ /pubmed/19902037 http://dx.doi.org/10.4103/0973-3930.41984 Text en © International Journal of Diabetes in Developing Countries http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
de Souza, Alexandre Leite
Metformin: From medieval age to new therapeutic targets
title Metformin: From medieval age to new therapeutic targets
title_full Metformin: From medieval age to new therapeutic targets
title_fullStr Metformin: From medieval age to new therapeutic targets
title_full_unstemmed Metformin: From medieval age to new therapeutic targets
title_short Metformin: From medieval age to new therapeutic targets
title_sort metformin: from medieval age to new therapeutic targets
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771999/
https://www.ncbi.nlm.nih.gov/pubmed/19902037
http://dx.doi.org/10.4103/0973-3930.41984
work_keys_str_mv AT desouzaalexandreleite metforminfrommedievalagetonewtherapeutictargets